stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: ELI LILLY & Co · CIK 0000059478

When will Eli Lilly & Co. file its next 10-Q?

LLY · NYSE
Snapshot

Eli Lilly & Co. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Oct. 30, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

Eli Lilly & Co.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 5, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Eli Lilly & Co. filed between 30 and 39 days after period end (median 31 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Eli Lilly & Co.: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 30 days later; 10-K for period ended 2024-12-31: filed 50 days later; 10-Q for period ended 2025-03-31: filed 31 days later; 10-Q for period ended 2025-06-30: filed 38 days later; 10-Q for period ended 2025-09-30: filed 30 days later; 10-K for period ended 2025-12-31: filed 43 days later; 10-Q for period ended 2026-03-31: filed 30 days later; 10-Q for period ended 2026-06-30: filed 36 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 30d 10-K · Dec. 31 24 50d 10-Q · March 31 25 31d 10-Q · June 30 25 38d 10-Q · Sept. 30 25 30d 10-K · Dec. 31 25 43d 10-Q · March 31 26 30d 10-Q · June 30 26 36d days from period end to filing date →

Recent filings by Eli Lilly & Co.

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-08-05 · Index 0000059478-26-000081
8-K Released earnings or financial results Open 8-K filed 2026-08-05 · Index 0000059478-26-000077
13D Ownership above 5% by an investor who may seek influence Open SCHEDULE 13D filed 2026-07-30 · Index 0000059478-26-000072
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-07-24 · Index 0000059478-26-000071
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-07-24 · Index 0000059478-26-000070
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-07-23 · Index 0000316011-26-000029
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-23 · Index 0000059478-26-000063
25-NSE Exchange notice removing a security from listing Open 25-NSE filed 2026-06-02 · Index 0000876661-26-000494
8-K Other events the company chose to report Open 8-K filed 2026-05-20 · Index 0001193125-26-232707
SD Specialized disclosure (conflict minerals / resource payments) Open SD filed 2026-05-11 · Index 0000059478-26-000051
8-K Reported shareholder vote results Open 8-K filed 2026-05-07 · Index 0000059478-26-000048
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-05-01 · Index 0002100119-26-001290
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-04-30 · Index 0000059478-26-000045
8-K Released earnings or financial results Open 8-K filed 2026-04-30 · Index 0000059478-26-000043
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-04-20 · Index 0000316011-26-000011
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-001113
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-20 · Index 0000059478-26-000031
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-20 · Index 0000059478-26-000029
PRE 14A Preliminary proxy statement Open PRE 14A filed 2026-03-06 · Index 0000059478-26-000021
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-12 · Index 0000059478-26-000013
8-K Released earnings or financial results Open 8-K filed 2026-02-04 · Index 0000059478-26-000008
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-01-23 · Index 0000316011-26-000007
13D Ownership above 5% by an investor who may seek influence Open SCHEDULE 13D filed 2026-01-15 · Index 0001193125-26-013469
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2025-11-21 · Index 0000059478-25-000271
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2025-10-30 · Index 0000316011-25-000041

What Eli Lilly & Co.'s 8-Ks were about in the past year

Eli Lilly & Co. filed 7 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits5
2.02Results of Operations and Financial Condition4
8.01Other Events1
5.07Submission of Matters to a Vote of Security Holders1
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers1

See what each 8-K item means.